🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 74765K105 (prev. 42984L204 )
- Market Cap
- Small Cap
- IPO
- 9/4/2020
- Previous Symbol
- CAPA (changed 6/14/2021)
- Previous Name
- HighCape Capital Acquisition Corp.
Business: Quantum-Si Inc. is focused on revolutionizing the growing field of proteomics. The company’s suite of technologies are powered by a first-of-its-kind semiconductor chip designed to enable single-molecule next-generation protein sequencing and genomics, and digitize proteomic research in order to advance drug discovery and diagnostics beyond what has been possible with DNA sequencing.
Notes: June 10, 2021-- Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSi” or “the Company”), a company pioneering next-generation semiconductor chip-based proteomics, today announced that it has completed its business combination with HighCape Capital Acquisition Corp. (Nasdaq: CAPA) (“HighCape”), a special purpose acquisition company sponsored by leading healthcare growth equity manager HighCape Capital LP. Following the transaction, the combined company was renamed Quantum-Si Incorporated, and its Class A common stock and warrants will begin trading on the Nasdaq Global Market (“Nasdaq”) on June 11, 2021 under the symbols “QSI” and “QSIAW,” respectively. The final Exchange Ratio for which the former Quantum-Si stockholders exchanged their shares of Quantum-Si capital stock for common stock of the combined company was 0.7975. Each share of HighCape Class A common stock and HighCape Class B common stock became one share of the combined company’s Class A common stock.
Company Contact
- CEO
- Jeff Hawkins
- CFO
- Jeff Keyes
- Headquarters
- 29 Business Park Drive, Guilford, CT 06405
- Phone
- 866-688-7374 · Toll-Free 866-688-7374
- Investor Relations
- Juan Avendano · 866-688-7374 · ir@quantum-si.com